PAM
Palisade Asset Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $339K | Sell |
4,335
-650
| -13% | -$50.8K | 0.03% | 168 |
|
|
2025
Q1 | $361K | Hold |
4,985
| – | – | 0.04% | 162 |
|
|
2024
Q4 | $369K | Hold |
4,985
| – | – | 0.04% | 162 |
|
|
2024
Q3 | $329K | Hold |
4,985
| – | – | 0.03% | 168 |
|
|
2024
Q2 | $460K | Hold |
4,985
| – | – | 0.05% | 158 |
|
|
2024
Q1 | $476K | Hold |
4,985
| – | – | 0.05% | 158 |
|
|
2023
Q4 | $380K | Sell |
4,985
-1,245
| -20% | -$94.9K | 0.04% | 159 |
|
|
2023
Q3 | $432K | Hold |
6,230
| – | – | 0.05% | 147 |
|
|
2023
Q2 | $588K | Hold |
6,230
| – | – | 0.07% | 136 |
|
|
2023
Q1 | $515K | Hold |
6,230
| – | – | 0.06% | 139 |
|
|
2022
Q4 | $465K | Hold |
6,230
| – | – | 0.05% | 150 |
|
|
2022
Q3 | $515K | Hold |
6,230
| – | – | 0.07% | 135 |
|
|
2022
Q2 | $592K | Hold |
6,230
| – | – | 0.08% | 132 |
|
|
2022
Q1 | $733K | Hold |
6,230
| – | – | 0.08% | 127 |
|
|
2021
Q4 | $807K | Hold |
6,230
| – | – | 0.09% | 121 |
|
|
2021
Q3 | $705K | Hold |
6,230
| – | – | 0.09% | 123 |
|
|
2021
Q2 | $645K | Hold |
6,230
| – | – | 0.08% | 127 |
|
|
2021
Q1 | $521K | Buy |
6,230
+20
| +0.3% | +$1.67K | 0.07% | 138 |
|
|
2020
Q4 | $567K | Buy |
6,210
+120
| +2% | +$11K | 0.08% | 131 |
|
|
2020
Q3 | $486K | Hold |
6,090
| – | – | 0.07% | 131 |
|
|
2020
Q2 | $421K | Buy |
6,090
+4,060
| +200% | +$281K | 0.07% | 134 |
|
|
2020
Q1 | $383K | Hold |
2,030
| – | – | 0.07% | 139 |
|
|
2019
Q4 | $474K | Buy |
+2,030
| New | +$474K | 0.07% | 134 |
|